ZA935642B - Peptides analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus - Google Patents

Peptides analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus

Info

Publication number
ZA935642B
ZA935642B ZA935642A ZA935642A ZA935642B ZA 935642 B ZA935642 B ZA 935642B ZA 935642 A ZA935642 A ZA 935642A ZA 935642 A ZA935642 A ZA 935642A ZA 935642 B ZA935642 B ZA 935642B
Authority
ZA
South Africa
Prior art keywords
protein
mixtures
detecting
rubella virus
eliciting antibodies
Prior art date
Application number
ZA935642A
Other languages
English (en)
Inventor
Maan Zrein
Martial Lacroix
Original Assignee
Biochem Immunosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Immunosystems Inc filed Critical Biochem Immunosystems Inc
Publication of ZA935642B publication Critical patent/ZA935642B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36211Rubivirus, e.g. rubella virus
    • C12N2770/36222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA935642A 1992-08-07 1993-08-04 Peptides analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus ZA935642B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/927,071 US5427792A (en) 1989-08-23 1992-08-07 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus

Publications (1)

Publication Number Publication Date
ZA935642B true ZA935642B (en) 1995-02-06

Family

ID=25454125

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935642A ZA935642B (en) 1992-08-07 1993-08-04 Peptides analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus

Country Status (13)

Country Link
US (1) US5427792A (xx)
EP (1) EP0656013B1 (xx)
JP (1) JP3492686B2 (xx)
AP (1) AP453A (xx)
AT (1) ATE192163T1 (xx)
AU (1) AU690070B2 (xx)
CA (1) CA2141670C (xx)
DE (1) DE69328488T2 (xx)
ES (1) ES2145055T3 (xx)
IL (1) IL106592A (xx)
PT (1) PT656013E (xx)
WO (1) WO1994003490A1 (xx)
ZA (1) ZA935642B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238660A1 (en) * 1998-05-22 1999-11-22 Janet Chantler Gene sequences of rubella virus associated with attenuation
ES2257095T3 (es) * 1998-12-01 2006-07-16 Viral Antigens, Inc. Especificidad mejorada en la deteccion de anticuerpos igm de anti-rubeola.
BR102018075339A2 (pt) * 2018-12-06 2021-11-16 Fundação Oswaldo Cruz Proteína recombinante, sequência de dna sintético, vetor de expressão, célula hospedeira, composição, kit para diagnóstico de rubéola, uso de pelo menos uma proteína recombinante, e, métodos para produzir uma proteína recombinante e para diagnóstico de rubéola
CN110423272A (zh) * 2019-08-15 2019-11-08 捷敏(天津)生物技术有限公司 一种新的抗风疹病毒膜蛋白e1的抗体及其应用技术领域

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003206A1 (en) * 1985-11-25 1987-06-04 Quash Gerard A Modified viral glycoproteins, diagnostic and therapeutic uses therefore
EP0299673A1 (en) * 1987-07-08 1989-01-18 London Biotechnology Limited Rubella E1 glycoprotein antigens
US5164481A (en) * 1989-08-23 1992-11-17 Iaf Biochem International Inc. Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine

Also Published As

Publication number Publication date
IL106592A (en) 2001-01-11
JP3492686B2 (ja) 2004-02-03
AP9300556A0 (en) 1993-10-31
DE69328488T2 (de) 2000-11-30
CA2141670C (en) 2007-03-06
PT656013E (pt) 2000-10-31
ATE192163T1 (de) 2000-05-15
JPH08502724A (ja) 1996-03-26
WO1994003490A1 (en) 1994-02-17
CA2141670A1 (en) 1994-02-17
EP0656013B1 (en) 2000-04-26
AU690070B2 (en) 1998-04-23
DE69328488D1 (de) 2000-05-31
IL106592A0 (en) 1993-12-08
EP0656013A1 (en) 1995-06-07
US5427792A (en) 1995-06-27
AP453A (en) 1996-01-20
ES2145055T3 (es) 2000-07-01
AU4693493A (en) 1994-03-03

Similar Documents

Publication Publication Date Title
EE9700137A (et) Peptiidide ja proteiinide aerosoolvormid
EP0273716A3 (en) Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
IL101425A0 (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus,methods for their use and pharmaceutical compositions containing the same
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
AU6979387A (en) Fusion protein comprising influenza virus haemagglutinin and antigenic epitope
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
AU1255383A (en) Foot and mouth disease viral antigenic peptides
EP0491844A4 (en) Peptides including ctl epitopes of hiv proteins and use thereof
DE69126577T2 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
GB9502489D0 (en) Expression of the non-structural protein NS1 of influenza virus and detection of anti-NS1 antibody in serum
EP0747482A3 (en) Recombinant hepatitis GB virus proteins their uses
AU2929689A (en) Idiotype and anti-idiotype antibodies useful in virus detection
ZA915286B (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
ZA935642B (en) Peptides analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
DK614589D0 (da) Imidazolholdige peptider samt fremgangsmaade til fremstilling deraf
IL118364A0 (en) A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus
ZA907279B (en) Antibodies and proteins
GR970300022T1 (en) Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus
ZA89266B (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
ZA893085B (en) Human immunodeficiency virus(hiv)env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
AU4327793A (en) Synthetic peptides for the detection of antibodies against the virus of hepatitis c in the serum of infected persons
IL83422A0 (en) Human b lymphotropic virus and method for the detection of antibodies thereto
EP0503252A3 (en) Recombinant proteins having the immunoreactivity of hepatitis b virus e antigens (hbeag), method for their production and their application in immunoassays and as vaccines
ZA924950B (en) Hcv peptide antigens and methods for the determination of hcv
IE892549L (en) Synthetic polypeptides and antibodies related to¹epstein-barr virus nuclear antigen